Skip to main content
logo
Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
6.06
-0.06 (-0.98%)
Jul 23, 2026, 9:19 AM AST

TADAWUL:9626 Financials Overview

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
45.4645.4633.9226.5221.92
Revenue Growth
21.89%34.02%27.88%20.99%-
Gross Profit
13.3113.3111.028.336.9
Operating Income
8.068.066.965.594.21
Net Income
7.37.36.34.873.78
Earnings Per Share
0.400.400.550.51-
EPS Growth
5.61%-25.77%6.42%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
39.3539.3520.058.125.16
Total Debt
14.2814.2811.794.375.12
Net Cash (Debt)
25.0725.078.253.750.04
Net Cash Growth
8.98%203.72%120.28%9671.36%-
Net Cash Per Share
1.391.390.710.39-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
11.3711.377.985.217.04
Capital Expenditures
-6.61-6.61-1.32-1.14-1.8
Free Cash Flow
4.764.766.664.075.24
Free Cash Flow Growth
24.65%-28.52%63.68%-22.33%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
29.29%29.29%32.50%31.41%31.46%
Operating Margin
17.72%17.72%20.53%21.07%19.20%
Pretax Margin
18.15%18.15%20.00%19.06%17.90%
Profit Margin
16.07%16.07%18.58%18.36%17.26%
FCF Margin
10.47%10.47%19.64%15.34%23.90%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
14.9614.11---
P/FCF Ratio
23.4221.64---
PS Ratio
2.452.27---